Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)

Authors:	Li Jian-Jun Lu Zong-Liang Kou Wen-Rong Bolli Roberto Chen Zuo Wu Yang-Feng Yu Xue-Hai Zhao Yu-Cheng

Affiliation:	^a Division of Dyslipidemia, Cardiovascular Medicine, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China ^b Division of Cardiology, University of Louisville, 201 Abraham Flexner Way Ste 1001, Louisville, KY, USA

Abstract:

Keywords:	Xuezhikang Abnormal liver test Myocardial infarction Cardiovascular event
本文献已被 ScienceDirect PubMed 等数据库收录！